Oncopeptides AB(DE:OND)
€0.16+0.01 (+10.07%)
DE:OND
Oncopeptides AB Revenue
€0.16
At close:+0.01 (+10.07%)
Oncopeptides AB (OND) Revenue
6 Followers
Oncopeptides AB Revenue
Oncopeptides AB had a revenue of 31.10M in the quarter ending Jun 30, 2026, with 22.51%. This bring the company's revenue in the last twelve months to 95.26M, Increased 14.30%. In the fiscal year ending Dec 31, 2025, Oncopeptides AB had annual revenue of 71.12M with 124.72% growth.
- Revenue (ttm)
- 95.26M
- Revenue Growth
- 69.05%
- P/S Ratio
- 0.98
- Revenue/Employee
- EUR 948,240
- Employees
- 75
- Market Cap
- EUR 69.90M
Revenue Chart
Oncopeptides AB Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 71.12M | 39.47M | 124.72% |
| Dec 31, 2024 | 31.65M | -3.57M | -10.14% |
| Dec 31, 2023 | 35.22M | 26.86M | 321.54% |
| Dec 31, 2022 | 8.36M | -109.94M | -92.94% |
| Dec 31, 2021 | 118.30M | 118.30M | ― |
| Dec 31, 2020 | 0.00 | 0.00 | ― |
| Dec 31, 2019 | 0.00 | 0.00 | ― |
| Dec 31, 2018 | 0.00 | 0.00 | ― |
| Dec 31, 2017 | 0.00 | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.